Posts by Sandra Ansanay-Alex
bNovate Technologies raises CHF 12 Million
bNovate Technologies, a leader in rapid bacterial detection systems for water, has announced a CHF 12 million Series C funding round, led by cleantech venture capital pioneer Emerald Technology Ventures and supported by existing shareholders. The cash injection will accelerate the Swiss-based company’s global expansion, while broadening its product portfolio, currently targeted at water…
Read MoreCHF 400’000 for Lymphatica
The FIT (Fondation pour l’Innovation Technologique) gives a Tech Growth loans of CHF 400’000 to the EPFL spin-off, allowing her to further develop its implant for lymphedema therapy and hire new team members. Lymphatica Medtech has invented a revolutionary system to treat lymphedema, a problem affecting millions of people worldwide. Lymphedema causes swollen limbs,…
Read MoreAbionic wins the Swiss Medtech Award 2023
The EPFL spin-off, founded in 2010, wins the Swiss Medtech Award 2023 valued at CHF 75,000. Abionic specialises in providing rapid diagnostic tests which function at proximity to the patient (Point-of-Care Testing). According to the jury, this technology could revolutionise in-vitro diagnostics. Around 800 representatives of the Swiss medical technology industry attended this year’s…
Read MoreEPHJ
EPHJ is taking place from 16 to 19 June 2026 in Palexpo Geneva This international trade show is dedicated to high precision and is the most important professional show held annually in Switzerland in the high-precision sector embracing jewellery and watchmaking subcontracting microtechnologies and medical technologies. The show presents numerous world premieres in all…
Read MoreRegen Lab partners with Dassault Systèmes Group
Regen Lab, a Swiss commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue engineering products announces that its US subsidiary, RegenLab USA LLC, has entered into a collaboration agreement with Long Island University (LIU) and Dassault Systèmes Group (3DS). This agreement is the result of an…
Read MoreHUG to test a promising messenger RNA vaccine against melanoma
A messenger RNA vaccine developed by Moderna, which has recently been shown to be effective against certain cases of melanoma, will soon be tested in Geneva. The HUG hopes to start the clinical trial in the summer or autumn of 2023. “The University Hospitals of Geneva (HUG) are one of the centres –…
Read MoreSwiss and American researchers reached a potential milestone in cancer therapy
Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough in the fight against cancer. They identified a previously unknown weak point of prostate cancer cells. This could also lead to entirely new therapeutic approaches for other types of cancer. Prostate cancer is the…
Read MoreViva Technology
Viva Technology is taking place on 17-20 June 2026 in Paris. Vivatechnology accelerates innovation by connecting startups, tech leaders, major corporations and investors. The event brings together all the key players responding to our world’s biggest challenge. More than 180’000 visitors and 14’000 startups are expected. The connections and collaborations between all these players…
Read MoreMerck inaugurates its Biotech Development Centre in Corsier-sur-Vevey
German laboratory Merck invested CHF 250 million in Corsier-sur-Vevey (VD). The 15,700 m2 building will combine research and production of biotechnology drugs and employ 250 people. The pharmaceutical company has invested more than 250 million Swiss francs in this “Biotech Development Centre”. It is dedicated to the development and production of active ingredients for…
Read MoreBIO US – San Diego
BIO International Convention, the premier event for the biotechnology industry, takes place from 22 to 25 June 2026 in San Diego (USA) The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.Whether you work at a public pharmaceutical…
Read More